Becton Dickinson BD Rhapsody TCR/BCR Multiomic Assay

Becton Dickinson has launched the BD Rhapsody TCR/BCR Multiomic Assay globally. The reagents enable profiling of full-length T cell and B cell receptors to advance research in autoimmune disorders, immuno-oncology, and infectious diseases. Applications for the assay include screening for antigen-specific cells in response to infectious diseases, immune repertoire profiling of tumor-infiltrating lymphocytes, and vaccine development and evaluation of efficacy. The assay is optimized to work with the BD Rhapsody Single-Cell Analysis System workflow.